Ergoteles’s Epizyme, Inc EPZM Stock Holding History

Ergoteles’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-649,100	Closed	-$954K	–	2225
2022 Q2	$954K	Buy	+649,100	New	+$477K	0.03%	561
2022 Q1	–	Sell	-129,782	Closed	-$324K	–	1767
2021 Q4	$324K	Buy	+129,782	New	+$510K	0.01%	827

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Ergoteles's EPZM Position: Q3 2022 in Review

Ergoteles sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 649,100 shares — an estimated $954K sold.

Ergoteles first reported a position in EPZM in Q4 2021 and held it in 2 quarters. The position peaked at $954K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Ergoteles reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 649,100 Epizyme, Inc shares in Q3 2022, an estimated $954K.
Ergoteles first reported a position in Epizyme, Inc in Q4 2021 and held it in 2 quarters.
Ergoteles's Epizyme, Inc position peaked at $954K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.